CGIM
MRNA icon

Cannon Global Investment Management’s Moderna MRNA Stock Holding History

Cannon Global Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,100
Closed -$728K – 66
2021
Q2 		$728K Buy
+3,100
New +$554K 1.42% 21

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Cannon Global Investment Management's MRNA Position: Q3 2021 in Review

Cannon Global Investment Management sold out of Moderna (MRNA) in Q3 2021, closing a stake of 3,100 shares — an estimated $728K sold.

Cannon Global Investment Management first reported a position in MRNA in Q2 2021 and held it in 1 quarter. The position peaked at $728K in Q2 2021. 1,141 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Cannon Global Investment Management reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • Cannon Global Investment Management sold 3,100 Moderna shares in Q3 2021, an estimated $728K.
  • Cannon Global Investment Management first reported a position in Moderna in Q2 2021 and held it in 1 quarter.
  • Cannon Global Investment Management's Moderna position peaked at $728K in Q2 2021.
  • 1,141 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Cannon Global Investment Management's 13F filing for Q3 2021, filed 27 Oct 2021.